Study: The Defense Research and Development Organization’s anti-COVID-19 drug 2-DG is effective against all variants of COVID-19 and reduces the risk Increase in the coronavirus. a new drug was proposed by the Defense Research and Development Organization (DRDO) and the laboratories of Dr. Reddy developed. The study was conducted by Annat Narayan Bhatt, Abhishek Kumar, Yogesh Rai, Dhiviya Vedagiri, and others, although it has not yet been peer-reviewed, ANI reported. “In this study, we used 2-deoxy-D-glucose (2-DG) to combat and inhibit the metabolic reprogramming induced by SARS-CoV-2 infection glycolysis induces a highly selective accumulation of the fluorescent glucose analogue / 2-DG, 2-NBDG in these cells, then 2-DG reduces virus replication and relieves the cells of the cytopathic effects induced by infection (CPE) and death. read the study.
